EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark INFINITY PHARMACEUTICALS was filed as Word mark on 01/11/2002 at the European Union Intellectual Property Office.
It was registered as a trademark on 01/28/2004.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 002547214 |
| Application date | January 11, 2002 |
| Publication date | July 7, 2003 |
| Entry date | January 28, 2004 |
| Expiration date | January 11, 2032 |
Trademark owner
784 Memorial Drive
02139 Cambridge,
US
02139 Cambridge,
US
Trademark representatives
Kaulbachstr. 114
80802 Munich
DE
goods and services
1
Diagnostic assays and test kits for clinical, laboratory and chemical use to diagnose, prognose, predict or treat diseases and for providing genomic and proteonic profiles useful in the selection of therapeutics; assays and test kits for evaluating efficacy of treatments and treatment progress; prognostic test kits for identifying hereditary risk factors; diagnostic preparations, namely, preparations of extracts, assays, nucleic acids, proteins, polypeptides, and antibodies and molecular arrays of biological materials for clinical or medical laboratory use; diagnostic assays and test kits for scientific, research and medical research use to diagnose, prognose, predict or treat diseases and for providing genomic and proteonic profiles useful in the selection of therapeutics
5
Prescription pharmaceutical preparations for use in the diagnosis or treatment of human diseases and disorders, namely, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral urinary, renal, infectious, metabolic or central nervous system diseases and disorders, excluding analgesics; diagnostic assays and test kits for clinical, laboratory, medical and chemical use to diagnose, prognose, predict or treat diseases and for providing genomic and proteomic profiles useful in the selection of therapeutics; assays and test kits for evaluating efficacy of treatments and treatment progress; prognostic test kits for identifying hereditary risk factors; diagnostic preparations, namely, preparations of extracts, assays, nucleic acids, proteins, polypeptides, and antibodies, and molecular arrays of biological materials for clinical or medical laboratory use
9
Computer programs and databases stored on CD-ROM in the field of genomics, diagnostics, pharmacogenomics, pharmaceuticals and biotechnology; computer programs for use in database management, integration and manipulation; computer programs for use in characterization of nucleic acid and protein information; computer programs for use in analyzing chemical structure and activity information; computer programs for use in acquisition and interrogation of clinical, pathological, diagnostic, genetic, genomic and biochemical data; computer programs for use in clinical trial design and management; computer programs for use in text and pattern recognition; computer programs for storage, retrieval and analysis of life sciences literature; computer programs for use in managing robot function; computer programs for use in processing toxicological and pharmacological information; computer programs for laboratory instrument control; computer programs for use in control of sample input to mass spectrometers; computer programs for use in spectral analysis; pre-recorded CD-ROMs featuring databases containing life sciences information; pre-configured microprocessors for analysis and storage of life sciences information
42
Medical and diagnostic services, namely, diagnosing, preventing, and predicting disease, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress; research services, namely, research, development, validation, testing, data analysis and product development services in the biomedical, genomic pharmacogenomic, diagnostic, clinical trial design, and biotechnology fields; research consulting services, namely, research, development, validation, testing, data analysis and product development services for others in the biomedical, genomic, pharmaceutical, pharmacogenomics, diagnostic, clinical trial design, and biotechnology fields; computer services, namely, providing access to databases of life sciences information via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology; computer consulting services, namely, providing access to databases of life sciences information to others via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| January 4, 2022 | Extension, Trade mark renewed | ||
| December 10, 2020 | Change Representative, Published | ||
| January 4, 2019 | Transfer / Change of address, Published | ||
| December 19, 2011 | Extension, Trade mark renewed | ||
| September 13, 2011 | Change Representative, Published | ||
| November 2, 2009 | Transfer / Change of address, Published | ||
| December 11, 2007 | Change Representative, Published | ||
| August 13, 2007 | Change Representative, Published |
ID: 11002547214